PURE Bioscience, Inc. is focused on developing and commercializing proprietary antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control. PURE Bioscience technology platform is based on patented, stabilized ionic silver, and initial products contain Silver Dihydrogen Citrate (SDC). SDC is a broad-spectrum, non-toxic antimicrobial agent that is manufactured as a liquid and delivered in various concentrations. The Company currently manufactures and distributes SDC-based disinfecting and sanitizing products, which are registered by the United States Environmental Protection Agency. PURE Bioscience also manufactures and sells SDC-based formulations to manufacturers for use as a raw material ingredient in the production of personal care products.

TypePrivate
HQEl Cajon, US
Founded1992
Size (employees)36 (est)+3%
Websitepurebio.com
PURE Bioscience was founded in 1992 and is headquartered in El Cajon, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

PURE Bioscience Office Locations

PURE Bioscience has an office in El Cajon
El Cajon, US (HQ)
1725 Gillespie Way
Show all (1)
Report incorrect company information

PURE Bioscience Financials and Metrics

Summary Metrics

Founding Date

1992

PURE Bioscience total Funding

$1.3 m

PURE Bioscience latest funding size

$1.27 m

Time since last funding

2 years ago
PURE Bioscience's latest funding round in May 2016 was reported to be $1.3 m. In total, PURE Bioscience has raised $1.3 m
Show all financial metrics

PURE Bioscience Revenue

USD

Net income (Q3, 2018)

(6.1m)

EBIT (Q3, 2018)

(5.7m)

Cash (30-Apr-2018)

1.0m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cost of goods sold

565.0k344.0k285.0k441.0k760.0k

General and administrative expense

5.7m5.1m4.9m5.1m

R&D expense

1.3m1.0m790.0k927.0k

Operating expense total

7.0m6.1m5.7m6.0m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cost of goods sold

45.0k111.0k65.0k54.0k48.0k116.0k265.0k134.0k132.0k146.0k307.0k473.0k

General and administrative expense

1.2m1.2m1.2m1.1m1.4m1.4m1.3m1.3m1.3m1.4m2.9m4.1m

R&D expense

176.0k215.0k171.0k236.0k238.0k205.0k248.0k214.0k222.0k144.0k264.0k381.0k

Operating expense total

1.4m1.4m1.4m1.3m1.6m1.6m1.6m1.5m1.5m2.4m4.8m6.9m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

32.0k86.0k1.3m5.2m1.6m

Accounts Receivable

18.0k47.0k189.0k263.0k297.0k

Inventories

350.0k27.0k

Current Assets

486.0k478.0k2.0m6.1m2.5m
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

5.3m3.9m2.5m6.1m6.7m5.4m4.1m3.9m2.7m3.2m2.1m1.0m

Accounts Receivable

47.0k40.0k86.0k93.0k106.0k68.0k146.0k142.0k185.0k143.0k146.0k192.0k

Inventories

231.0k186.0k207.0k219.0k237.0k320.0k348.0k340.0k348.0k274.0k267.0k275.0k

Current Assets

5.8m4.2m2.9m6.6m7.2m6.2m5.0m4.6m3.5m3.9m2.7m1.6m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(7.7m)(11.0m)(7.6m)(14.4m)(6.3m)

Depreciation and Amortization

311.0k248.0k219.0k

Inventories

149.0k(12.0k)(143.0k)27.0k

Accounts Payable

560.0k426.0k
Quarterly
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

(1.9m)(1.7m)(2.1m)(2.8m)(10.9m)30.0k(1.7m)(936.0k)(1.7m)(2.3m)(4.4m)(6.1m)

Depreciation and Amortization

71.0k142.0k213.0k

Inventories

(1.0k)(20.0k)17.0k

Accounts Payable

510.0k510.0k533.0k384.0k582.0k522.0k654.0k424.0k574.0k(38.0k)7.0k(52.0k)
USDY, 2018

Financial Leverage

1.3 x
Show all financial metrics
Report incorrect company information

PURE Bioscience Online and Social Media Presence

Embed Graph
Report incorrect company information

PURE Bioscience News and Updates

Report incorrect company information

PURE Bioscience Company Life and Culture

Report incorrect company information